Race to stop suicide: single dose vs. single session in High-Stakes trial
NCT ID NCT07120477
Summary
This study aims to prevent suicide attempts by comparing two fast-acting approaches for people in crisis. It will test if a single dose of the medication esketamine or a single session to create a personalized crisis plan is better than standard emergency care alone. The trial will enroll 468 adolescents and adults in Brazil who recently attempted suicide or have severe suicidal thoughts, following them for one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDE PREVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.